Decentralized Development of Gene Therapies for Ultra-Rare Disorders

Time: 4:15 pm
day: Day One PM

Details:

• Realizing the full value potential for investing into Gene Therapies for Ultra-Rare Disorders
• Strategies and tools for decentralized funding of low-cost CMC platforms for viral vectored Gene Therapies
• Lowering the patient prevalence threshold for financial sustainability through greater industry collaboration

Speakers:

Chris Williams Chris has evolved his understanding of the challenges in drug development through 14 years of experience in technical development and manufacturing of biologics. Chris is challenging Read more